yttrium radioisotopes has been researched along with Glioblastoma in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Y; Chong, HS; Kang, CS; Kweon, J; Lee, H; Lewis, MR; Liu, D; Sun, X | 1 |
Bartolomei, M; Bodei, L; Grana, C; Handkiewicz-Junak, D; Maira, G; Mazzetta, C; Paganelli, G; Rocca, P; Sturiale, C; Villa, G | 1 |
Bartolomei, M; Bodei, L; Boiardi, A; Botturi, A; Broggi, G; Eoli, M; Lamperti, E; Milanesi, I; Paganelli, G; Rocca, P; Salmaggi, A; Silvani, A | 1 |
Dale, RG; Sparks, RB; Stefanou, SS | 1 |
Bartolomei, M; Caliceti, P; Chinol, M; De Cicco, C; Fiorenza, M; Gatti, M; Grana, C; Mazzetta, C; Paganelli, G; Robertson, C | 1 |
Diao, GP; Dong, GZ; Kang, GQ; Li, SY; Liu, ZH; Tian, ZM; Wang, YG | 1 |
Dillehay, LE; Edwards, JA; Klein, JL; Order, SE; Poggenburg, JK; Wanek, PM; Wessels, BW; Wharam, MD; Williams, JA | 1 |
3 trial(s) available for yttrium radioisotopes and Glioblastoma
Article | Year |
---|---|
Combined treatment of glioblastoma patients with locoregional pre-targeted 90Y-biotin radioimmunotherapy and temozolomide.
Topics: Antineoplastic Agents, Alkylating; Biotin; Brain Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Drug Delivery Systems; Female; Glioblastoma; Humans; Italy; Male; Middle Aged; Radioimmunotherapy; Radiopharmaceuticals; Survival Analysis; Temozolomide; Treatment Outcome; Yttrium Radioisotopes | 2004 |
Intratumoral delivery of mitoxantrone in association with 90-Y radioimmunotherapy (RIT) in recurrent glioblastoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Marrow Diseases; Brain Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Drug Delivery Systems; Glioblastoma; Humans; Infusions, Intralesional; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Pilot Projects; Radioimmunotherapy; Yttrium Radioisotopes | 2005 |
Pretargeted adjuvant radioimmunotherapy with yttrium-90-biotin in malignant glioma patients: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Avidin; Biotin; Brain Neoplasms; Female; Glioblastoma; Glioma; Humans; Immunoconjugates; Male; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Yttrium Radioisotopes | 2002 |
4 other study(ies) available for yttrium radioisotopes and Glioblastoma
Article | Year |
---|---|
Synthesis and evaluation of a new bifunctional NETA chelate for molecular targeted radiotherapy using(90)Y or(177)Lu.
Topics: Animals; Cell Line, Tumor; Chelating Agents; Chemistry Techniques, Synthetic; Drug Stability; Glioblastoma; Heterocyclic Compounds; Humans; Isotope Labeling; Kinetics; Lutetium; Mice; Molecular Targeted Therapy; Oligopeptides; Tissue Distribution; Yttrium Radioisotopes | 2015 |
A theoretical investigation into post-operative, intracavitary beta therapy of high-grade glioblastomas using yttrium-90.
Topics: Apoptosis; Beta Particles; Cell Proliferation; Cell Survival; Computer Simulation; Glioblastoma; Humans; Injections, Intralesional; Models, Biological; Postoperative Care; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Relative Biological Effectiveness; Treatment Outcome; Yttrium Radioisotopes | 2006 |
CT-guided stereotactic injection of radionuclide in treatment of brain tumors.
Topics: Adolescent; Adult; Aged; Astrocytoma; Brachytherapy; Brain Neoplasms; Child; Child, Preschool; Craniopharyngioma; Female; Glioblastoma; Gold Radioisotopes; Humans; Male; Middle Aged; Phosphorus Radioisotopes; Stereotaxic Techniques; Tomography, X-Ray Computed; Yttrium Radioisotopes | 1992 |
Targeting and therapy of human glioma xenografts in vivo using radiolabeled antibodies.
Topics: Animals; Antibodies, Monoclonal; Glioblastoma; Humans; Immunohistochemistry; Indium Radioisotopes; Male; Mice; Mice, Nude; Neoplasm Transplantation; Radiation Dosage; Survival Rate; Transplantation, Heterologous; Yttrium Radioisotopes | 1990 |